lg 100268 has been researched along with Acute Promyelocytic Leukemia in 3 studies
LG 100268: a retinoid X receptor (RXR) selective compound; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehm, MF | 1 |
| Zhang, L | 1 |
| Zhi, L | 1 |
| McClurg, MR | 1 |
| Berger, E | 1 |
| Wagoner, M | 1 |
| Mais, DE | 1 |
| Suto, CM | 1 |
| Davies, JA | 1 |
| Heyman, RA | 1 |
| Xu, T | 1 |
| Zhong, L | 1 |
| Gan, LG | 1 |
| Xiao, CL | 1 |
| Shan, ZL | 1 |
| Yang, R | 1 |
| Song, H | 1 |
| Li, L | 1 |
| Liu, BZ | 1 |
| Tabe, Y | 1 |
| Konopleva, M | 1 |
| Kondo, Y | 1 |
| Contractor, R | 1 |
| Tsao, T | 1 |
| Konoplev, S | 1 |
| Shi, Y | 1 |
| Ling, X | 1 |
| Watt, JC | 1 |
| Tsutsumi-Ishii, Y | 1 |
| Ohsaka, A | 1 |
| Nagaoka, I | 1 |
| Issa, JP | 1 |
| Kogan, SC | 1 |
| Andreeff, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Study of Bexarotene in Patients With Acute Myeloid Leukemia[NCT00316030] | Phase 1 | 54 participants | Interventional | 2004-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for lg 100268 and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.
Topics: Apoptosis; Bexarotene; Binding, Competitive; Cell Line; Drug Design; Humans; Leukemia, Promyelocytic | 1995 |
Effects of LG268 on Cell Proliferation and Apoptosis of NB4 Cells.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, | 2016 |
PPARgamma-active triterpenoid CDDO enhances ATRA-induced differentiation in APL.
Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Line, Tumor; Drug | 2007 |